Nationwide Fund Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-38,350
| Closed | -$1.45M | – | 22 |
|
|
2017
Q3 | $1.45M | Buy |
38,350
+11,410
| +42% | +$430K | 0.01% | 1599 |
|
|
2017
Q2 | $751K | Buy |
26,940
+14,600
| +118% | +$407K | ﹤0.01% | 1952 |
|
|
2017
Q1 | $424K | Buy |
+12,340
| New | +$424K | ﹤0.01% | 2241 |
|
|
2016
Q4 | – | Sell |
-36,330
| Closed | -$1.16M | – | 3192 |
|
|
2016
Q3 | $1.16M | Buy |
36,330
+9,010
| +33% | +$287K | ﹤0.01% | 1690 |
|
|
2016
Q2 | $887K | Sell |
27,320
-27,227
| -50% | -$884K | ﹤0.01% | 1801 |
|
|
2016
Q1 | $1.55M | Sell |
54,547
-12,096
| -18% | -$343K | 0.01% | 1477 |
|
|
2015
Q4 | $2.38M | Buy |
66,643
+15,282
| +30% | +$545K | 0.01% | 1285 |
|
|
2015
Q3 | $1.7M | Sell |
51,361
-281
| -0.5% | -$9.3K | 0.01% | 1455 |
|
|
2015
Q2 | $2.16M | Sell |
51,642
-70,916
| -58% | -$2.97M | 0.01% | 1389 |
|
|
2015
Q1 | $3.99M | Buy |
122,558
+62,669
| +105% | +$2.04M | 0.02% | 1093 |
|
|
2014
Q4 | $1.9M | Sell |
59,889
-746
| -1% | -$23.7K | 0.01% | 1442 |
|
|
2014
Q3 | $1.5M | Buy |
60,635
+14
| +0% | +$347 | 0.01% | 1599 |
|
|
2014
Q2 | $1.37M | Buy |
+60,621
| New | +$1.37M | 0.01% | 1697 |
|
|
2014
Q1 | – | Sell |
-54,212
| Closed | -$1.36M | – | 3052 |
|
|
2013
Q4 | $1.36M | Sell |
54,212
-1,533
| -3% | -$38.3K | 0.01% | 1699 |
|
|
2013
Q3 | $1.53M | Buy |
55,745
+33,211
| +147% | +$912K | 0.01% | 1596 |
|
|
2013
Q2 | $409K | Buy |
+22,534
| New | +$409K | ﹤0.01% | 2105 |
|